Page last updated: 2024-11-12

penberol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Penberol: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10246667
MeSH IDM0059517

Synonyms (12)

Synonym
nsc-172760
penberol
2-butenoic acid, 3-bromo-4-oxo-4-(4-(pentyloxy)phenyl)-, (e)-
brn 2132369
(e)-3-bromo-4-oxo-4-(4-(pentyloxy)phenyl)-2-butenoic acid
nsc 172760
unii-5kai8n485t
5kai8n485t ,
42241-78-1
2-butenoic acid, 3-bromo-4-oxo-4-(4-(pentyloxy)phenyl)-, (2e)-
(2e)-3-bromo-4-oxo-4-(4-(pentyloxy)phenyl)-2-butenoic acid
(e)-3-bromo-4-oxo-4-(4-pentoxyphenyl)but-2-enoic acid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (10.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]